| Companies sponsors |
Theramex (abaloparatide) |
| Others |
Department of Health and Social Care |
| |
Health Technology Wales (HTW) |
| |
NHS England |
| Patient carer groups |
Royal Osteoporosis Society |
| Professional groups |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Assessment group |
School of Health and Related Research (ScHARR) |
| Associated public health groups |
None |
| Comparator companies |
Accord Healthcare (alendronic acid, ibandronic acid, teriparatide) (confidentiality agreement not signed, not participating) |
| |
Accord-UK (raloxifene, risedronate sodium) (confidentiality agreement not signed, not participating) |
| |
Amgen (denosumab) (confidentiality agreement not signed, not participating) |
| |
Aristo Pharma (risedronate sodium, strontium ranelate) (confidentiality agreement not signed, not participating) |
| |
Aspire Pharma (ibandronic acid, raloxifene, risedronate sodium) (confidentiality agreement not signed, not participating) |
| |
Atnahs Pharma (ibandronic acid) (confidentiality agreement not signed, not participating) |
| |
Aurobindo Pharma - Milpharm (alendronic acid, risedronate sodium) (confidentiality agreement not signed, not participating) |
| |
Dr. Reddy's Laboratories (zoledronic acid) (confidentiality agreement not signed, not participating) |
| |
Eli Lilly (teriparatide) (confidentiality agreement not signed, not participating) |
| |
Gedeon Richter (teriparatide) (confidentiality agreement not signed, not participating) |
| |
Internis Pharmaceuticals (alendronic acid) (confidentiality agreement not signed, not participating) |
| |
Mylan (ibandronic acid) (confidentiality agreement not signed, not participating) |
| |
Novartis (zoledronic acid) (confidentiality agreement not signed, not participating) |
| |
Organon Pharma (alendronic acid) (confidentiality agreement not signed, not participating) |
| |
Ranbaxy (UK) Limited a Sun Pharmaceutical Company (zoledronic acid) (confidentiality agreement not signed, not participating) |
| |
Rosemont (alendronic acid) (confidentiality agreement not signed, not participating) |
| |
Sandoz (risedronate sodium, ibandronic acid) (confidentiality agreement not signed, not participating) |
| |
Seacross Pharmaceuticals (zoledronic acid) (confidentiality agreement not signed, not participating) |
| |
Teva UK (teriparatide) (confidentiality agreement not signed, not participating) |
| |
Thornton & Ross (teriparatide) (confidentiality agreement not signed, not participating) |
| |
UCB Pharma (romosozumab) (confidentiality agreement not signed, not participating) |
| |
Vygoris (raloxifene) (confidentiality agreement not signed, not participating) |
| |
Zentiva (ibandronic acid) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
National Institute of Health Research |